Correction: Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationCorrection: Novel Fusion Superkine, IL-24S/IL-15, Enhances Immunotherapy of Brain Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationCorrection: Novel Fusion Superkine, IL-24S/IL-15, Enhances Immunotherapy of Brain Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.